Ubag, Luna C.
HRN: 18-10-36 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2022
CO-AMOXICLAV 625MG (TAB)
11/13/2022
11/20/2022
PO
625mg
BID
Prophylaxis
Waiting Final Action